FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
Listen to an audio podcast of the August 28, 2019 FDA Drug Safety Communication: FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi with advanced liver disease. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 21, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
SCCM Pod-400 Are AKI Biomarkers Ready for Clinical Use?
Kyle B. Enfield, MD, FCCM, and Azra Bihorac, MD, MS, FCCM, discuss best practices and complexities of implementing biomarkers for kidney stress and acute kidney injury (AKI) and what the future holds for AKI biomarker literature. (Source: SCCM PodCast - iCritical Care)
Source: SCCM PodCast - iCritical Care - November 20, 2019 Category: Intensive Care Authors: The Society of Critical Care Medicine (SCCM) Tags: Medicine Source Type: podcasts
Maternal Infant Outcomes of Umbilical Cord Management, Ubrogepant for Migraine, Vitamin D and Kidney Function in T2DM, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 19, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 19, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts
14 November 2019: A rapid, multi-material 3D printer, and a bacterium ’s role in alcoholic hepatitis
This week, a new 3D printer allows quick shifting between many materials, and understanding the link between gut microbes and liver disease.00:46 A new dimension for 3D printersA new nozzle lets a 3D printer switch between materials at a rapid rate, opening the door to a range of applications. Research Article: Skylar-Scott et al.; News and Views: How to print multi-material devices in one go08:07 Research HighlightsThe slippery secrets of ice, and cells wrapping up their nuclei. Research Highlight: Viscous water holds the secret to an ice skater’s smooth glide; Research Highlight: ...
Source: Nature Podcast - November 13, 2019 Category: Science Authors: Springer Nature Limited Source Type: podcasts
14 November 2019: A rapid, multi-material 3D printer, and a bacterium ’s role in alcoholic hepatitis
This week, a new 3D printer allows quick shifting between many materials, and understanding the link between gut microbes and liver disease.00:46 A new dimension for 3D printersA new nozzle lets a 3D printer switch between materials at a rapid rate, opening the door to a range of applications. Research Article: Skylar-Scott et al.; News and Views: How to print multi-material devices in one go08:07 Research HighlightsThe slippery secrets of ice, and cells wrapping up their nuclei. Research Highlight: Viscous water holds the secret to an ice skater’s smooth glide; Research Highlight: ...
Source: Nature Podcast - November 13, 2019 Category: Science Authors: Springer Nature Limited Source Type: podcasts
The Advancing American Kidney Health Executive Order
Interview with Francisco G. Cigarroa, MD, author of The Advancing American Kidney Health Executive Order: An Opportunity to Enhance Organ Donation (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - September 20, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts
FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
Listen to an audio podcast of the August 28, 2019 FDA Drug Safety Communication: FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi with advanced liver disease. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - September 11, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Mycophenolate vs Methotrexate for Uveitis, Home-Based Physical Therapy After Hip Fracture, Dialysis Facility Ownership Profit Status and Kidney Transplantation, and more
September 10, 2019 edition of the weekly JAMA Editors' Summary (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - September 10, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts
